CBU
CVS icon

CIBC Bank USA’s CVS Health CVS Stock Holding History

CIBC Bank USA’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$781K Buy
10,513
+662
+7% +$46.5K 0.1% 124
2019
Q3 		$621K Sell
9,851
-364
-4% -$21.6K 0.09% 135
2019
Q2 		$557K Buy
10,215
+518
+5% +$27.9K 0.08% 151
2019
Q1 		$523K Buy
9,697
+1,871
+24% +$115K 0.07% 150
2018
Q4 		$513K Sell
7,826
-1,309
-14% -$97.7K 0.08% 137
2018
Q3 		$718K Buy
9,135
+770
+9% +$55K 0.1% 115
2018
Q2 		$539K Buy
8,365
+220
+3% +$14.5K 0.07% 145
2018
Q1 		$507K Buy
8,145
+259
+3% +$18.6K 0.07% 149
2017
Q4 		$572K Buy
7,886
+1,926
+32% +$140K 0.07% 146
2017
Q3 		$484K Buy
5,960
+131
+2% +$10.4K 0.06% 157
2017
Q2 		$468K Buy
5,829
+1,340
+30% +$106K 0.06% 159
2017
Q1 		$352K Buy
4,489
+1,615
+56% +$129K 0.05% 182
2016
Q4 		$227K Sell
2,874
-4,233
-60% -$343K 0.03% 230
2016
Q3 		$633K Sell
7,107
-1,530
-18% -$144K 0.1% 128
2016
Q2 		$827K Sell
8,637
-930
-10% -$92.7K 0.13% 101
2016
Q1 		$992K Buy
9,567
+546
+6% +$53.1K 0.17% 79
2015
Q4 		$882K Buy
9,021
+1,562
+21% +$153K 0.15% 91
2015
Q3 		$720K Sell
7,459
-3,029
-29% -$318K 0.13% 104
2015
Q2 		$1.1M Sell
10,488
-51
-0.5% -$5.21K 0.18% 80
2015
Q1 		$1.09M Buy
10,539
+644
+7% +$65.2K 0.19% 78
2014
Q4 		$953K Sell
9,895
-525
-5% -$46.3K 0.17% 97
2014
Q3 		$830K Sell
10,420
-2,454
-19% -$193K 0.17% 105
2014
Q2 		$971K Sell
12,874
-222
-2% -$16.8K 0.18% 94
2014
Q1 		$980K Buy
13,096
+860
+7% +$60.7K 0.2% 97
2013
Q4 		$876K Buy
12,236
+505
+4% +$32.4K 0.19% 116
2013
Q3 		$666K Sell
11,731
-60,097
-84% -$3.58M 0.16% 139
2013
Q2 		$4.11M Buy
+71,828
New +$4.16M 0.24% 78

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CIBC Bank USA's CVS Position: Q4 2019 in Review

CIBC Bank USA increased its CVS Health (CVS) stake by 6.7% in Q4 2019, buying an estimated $46.5K and bringing the position to 10,513 shares worth $781K. The position accounts for 0.1% of the portfolio, ranked #124.

CIBC Bank USA first reported a position in CVS in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.11M in Q2 2013. 1,843 funds tracked by Wall St. Rank hold CVS as of Q4 2019.

  • CIBC Bank USA held 10,513 shares of CVS Health worth $781K as of Q4 2019.
  • CIBC Bank USA bought 662 CVS Health shares in Q4 2019, an estimated $46.5K.
  • CVS Health made up 0.1% of CIBC Bank USA's portfolio in Q4 2019, its #124 holding.
  • CIBC Bank USA first reported a position in CVS Health in Q2 2013 and has held it in 27 quarters since.
  • CIBC Bank USA's CVS Health position peaked at $4.11M in Q2 2013.
  • 1,843 funds tracked by Wall St. Rank held CVS Health as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.